InMode Ltd. Stock Plummets to New 52-Week Low at $12.95

InMode Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 12.95 as of March 9, 2026. This decline marks a significant downturn for the company, which has experienced a 28.66% drop in its stock price over the past year, contrasting sharply with the S&P 500's performance of 17.78% during the same period. The company's financial metrics reveal a challenging landscape, with a price-to-earnings ratio of 8.00 and a return on equity of 13.73%. InMode has reported negative results for five consecutive quarters, with its operating cash flow hitting a low of USD 90.42 million and net profit for the latest quarter falling by 67.35% to USD 27.03 million. Additionally, the company's return on capital employed (ROCE) stands at a low 13.53%. With a market capitalization of USD 1,239 million, InMode's stock has underperformed against the S&P 500 over the last three years, generating returns of -31.49% in the past year alone. The stock's previous 52-week high was USD 19.78, highlighting the extent of its recent decline.